S Squared Technology, LLC Krystal Biotech, Inc. Transaction History

S Squared Technology, LLC

$218 Million
Q1 2024

A detailed history of S Squared Technology, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, S Squared Technology, LLC holds 90,215 shares of KRYS stock, worth $16 Million. This represents 7.37% of its overall portfolio holdings.

Number of Shares

90,215

Previous 110,215 18.15%

Holding current value

$16 Million

Previous $13.7 Million 17.39%

% of portfolio

7.37%

Previous 6.64%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$108.01 - $179.35 $2.16 Million - $3.59 Million	-20,000 Reduced 18.15%	90,215 $16.1 Million
Q4 2023 Feb 13, 2024	BUY	$96.0 - $128.29 $192,000 - $256,579	2,000 Added 1.85%	110,215 $13.7 Million
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $675,870 - $937,430	13,000 Added 13.65%	108,215 $7.2 Million
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $398,100 - $882,400	10,000 Added 11.74%	95,215 $6.66 Million
Q4 2020 Feb 12, 2021	BUY	$40.64 - $61.38 $203,200 - $306,900	5,000 Added 6.23%	85,215 $5.11 Million

Q3 2020 Nov 13, 2020	BUY	$37.76 - $48.49 $377,600 - $484,900	10,000 Added 14.24%	80,215 $3.45 Million
Q2 2020 Aug 13, 2020	BUY	$37.03 - $60.0 $370,300 - $600,000	10,000 Added 16.61%	70,215 $2.91 Million
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $242,738 - $477,353	-7,318 Reduced 10.84%	60,215 $3.34 Million
Q2 2019 Aug 12, 2019	SELL	$27.2 - $41.2 $37,182 - $56,320	-1,367 Reduced 1.98%	67,533 $2.72 Million
Q1 2019 May 14, 2019	SELL	$19.86 - $32.9 $99,300 - $164,500	-5,000 Reduced 6.77%	68,900 $2.27 Million
Q4 2018 Feb 13, 2019	BUY	$15.03 - $25.38 $300,600 - $507,600	20,000 Added 37.11%	73,900 $1.54 Million
Q3 2018 Nov 13, 2018	BUY	$14.43 - $21.0 $777,777 - $1.13 Million	53,900 New	53,900 $948,000

Others Institutions Holding KRYS

# of Institutions

262

Shares Held

21.5M

Call Options Held

462K

Put Options Held

723K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.56B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S Squared Technology, LLC, based on Form 13F filings with the SEC.

News

Stay updated on S Squared Technology, LLC with notifications on news.

Account

S Squared Technology, LLC Krystal Biotech, Inc. Transaction History